Evaluation of cold-recombinant influenza A/Korea (CR-59) virus vaccine in infants.
Twenty-four infants 5 to 13 months of age were intranasally vaccinated with a live cold-recombinant influenza A/Korea (CR-59, H3N2) virus vaccine. Nineteen infants served as controls. The inocula ranged from 10(3.2) to 10(6.2) 50% tissue culture infective doses (TCID50) per infant. Zero of six, one...
Guardat en:
| Publicat a: | J Clin Microbiol |
|---|---|
| Autors principals: | , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
American Society for Microbiology (ASM)
1989
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC267453/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/2745699/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/jcm.27.5.909-914.1989 |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|